Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study.
Sailish HonapLulia Al-HillawiSamantha BaillieAaron BancilLawrence MatiniRebecca LauKlaartje Bel KokKamal V PatelAlissa WalshPeter M IrvingMark A SamaanPublished in: Frontline gastroenterology (2022)
In the largest real-world study to date, ustekinumab was effective with a reassuring safety profile in a refractory cohort of patients.